University Hospital at Stony Brook

University Hospital at Stony Brook was paid $12.06M by Medicaid between Jan 2018 and Dec 2024, across 228 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.

33Billing provider infoUNIVERSITY HOSPITAL AT STONY BROOK
SOUTHAMPTON, NY 11968

33aNPI1033224704assigned 08/20/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$12.06M

24GClaims391,222

24DCodes billed228

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#75 of 231

Median peer was paid$561K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	15,859	$429K
2019	32,915	$804K
2020	60,165	$1.59M
2021	73,748	$2.28M
2022	72,865	$2.68M
2023	77,076	$2.46M
2024incomplete	58,594	$1.82M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	18%	10,604	10,247	$2.17M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	6.8%	4,626	4,459	$814K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	5.2%	7,232	6,291	$629K
96361	Intravenous infusion, hydration; each additional hour	4.7%	2,017	1,940	$566K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	4.1%	6,572	1,680	$495K
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.0%	2,290	2,237	$478K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	3.6%	3,549	3,427	$435K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	3.2%	2,135	432	$388K
74177	Computed tomography, abdomen and pelvis; with contrast material	2.6%	1,128	1,101	$315K
70450	Computed tomography, head or brain; without contrast material	2.1%	915	902	$254K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	2.1%	7,396	7,334	$249K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	2.1%	3,068	842	$247K

216 more codes

80053	Comprehensive metabolic panel	2.0%	19,565	$235K
77067	Screening mammography, bilateral, including computer-aided detection	1.8%	2,333	$223K
80048	Basic metabolic panel (calcium, ionized)	1.8%	10,962	$213K
0202U	Oncology (prostate), multianalyte, gene expression profiling	1.7%	2,616	$201K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.6%	918	$199K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	1.6%	502	$196K
99285	Emergency room visit (most serious)	1.3%	1,037	$159K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	1.3%	5,591	$159K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.3%	5,891	$152K
84443	Thyroid stimulating hormone (TSH)	1.1%	13,833	$134K
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.1%	1,023	$132K
99214	Doctor's office visit, returning patient (more involved)	1.1%	723	$128K
80061	Lipid panel	<1%	14,762	$108K
99213	Doctor's office visit, returning patient (routine)	<1%	534	$106K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,156	$105K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	3,733	$100K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,053	$95K
86480		<1%	1,568	$94K
80076		<1%	7,281	$89K
G0378	Hospital observation service, per hour	<1%	259	$70K
82607		<1%	5,053	$68K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	315	$67K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	607	$61K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	3,130	$58K
86703		<1%	3,420	$56K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	18,776	$55K
36415	Collection of venous blood by venipuncture	<1%	24,989	$55K
84439		<1%	5,035	$53K
71046	Radiologic examination, chest; 2 views	<1%	2,434	$47K
86780		<1%	3,368	$45K
86900		<1%	1,813	$42K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	832	$39K
82746		<1%	3,044	$39K
76642		<1%	1,034	$37K
85027		<1%	11,909	$35K
82728		<1%	2,354	$34K
87088		<1%	4,527	$34K
76770		<1%	202	$33K
86901		<1%	1,794	$32K
86618		<1%	1,790	$31K
87070		<1%	3,889	$30K
77063	Screening digital breast tomosynthesis, bilateral	<1%	2,333	$30K
86003		<1%	1,132	$30K
97010		<1%	1,937	$29K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	516	$28K
84403		<1%	844	$26K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	414	$26K
87077		<1%	3,022	$26K
84436		<1%	4,725	$26K
99215	Doctor's office visit, returning patient (complex)	<1%	132	$25K
59025	Fetal non-stress test	<1%	75	$22K
83655		<1%	1,340	$21K
84153		<1%	1,115	$21K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	63	$19K
86769		<1%	539	$19K
86850		<1%	1,472	$18K
81001		<1%	7,429	$18K
77066	Tomosynthesis, mammo	<1%	188	$18K
87503		<1%	516	$18K
84402		<1%	588	$18K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	102	$18K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	278	$17K
77080		<1%	194	$17K
86665		<1%	769	$17K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	1,141	$16K
29515		<1%	51	$16K
84681		<1%	562	$14K
83540		<1%	2,707	$14K
76641		<1%	299	$14K
88142		<1%	531	$14K
97535	Self-care/home management training, each 15 minutes	<1%	311	$14K
86376		<1%	794	$13K
97162		<1%	88	$13K
97124		<1%	297	$13K
87186		<1%	2,167	$13K
83001		<1%	565	$13K
86140		<1%	2,629	$13K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	2,084	$12K
83550		<1%	2,306	$12K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	37	$12K
83735		<1%	6,489	$12K
85610		<1%	3,208	$11K
86803		<1%	1,133	$11K
82784		<1%	868	$11K
73610		<1%	760	$11K
82248		<1%	2,058	$11K
83002		<1%	459	$10K
82043		<1%	1,915	$10K
83970		<1%	218	$10K
81003		<1%	7,154	$10K
86317		<1%	814	$10K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	25	$10K
73630		<1%	956	$9K
85652		<1%	3,890	$9K
97035		<1%	415	$9K
86038		<1%	1,454	$9K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	266	$9K
87338		<1%	800	$9K
86617		<1%	532	$8K
96375	Therapeutic injection; each additional sequential IV push	<1%	1,190	$8K
83516		<1%	694	$8K
73562		<1%	521	$8K
82570		<1%	1,544	$8K
84146		<1%	337	$8K
86255		<1%	1,060	$7K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	3,928	$7K
86800		<1%	457	$7K
90791	Psychiatric diagnostic evaluation	<1%	15	$7K
87536		<1%	93	$7K
76830	Ultrasound, transvaginal	<1%	134	$6K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	142	$6K
83690		<1%	3,286	$6K
86141		<1%	540	$6K
87340		<1%	570	$6K
81025		<1%	1,580	$5K
84481		<1%	525	$5K
84100		<1%	4,987	$5K
85730		<1%	1,438	$5K
86431		<1%	857	$5K
87205		<1%	1,446	$5K
84479		<1%	1,937	$5K
82550		<1%	1,171	$5K
73110		<1%	336	$5K
83525		<1%	304	$4K
77065	Tomosynthesis, mammo	<1%	46	$4K
86664		<1%	223	$4K
82670		<1%	129	$4K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	21	$4K
87641		<1%	127	$4K
86706		<1%	370	$4K
82785		<1%	218	$4K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	12	$4K
76536		<1%	96	$3K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	86	$3K
86762		<1%	211	$3K
73030		<1%	239	$3K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,526	$3K
86666		<1%	253	$3K
73130		<1%	290	$3K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	37	$3K
86364		<1%	238	$2K
72100		<1%	97	$2K
87046		<1%	228	$2K
84480		<1%	327	$2K
85007		<1%	1,639	$2K
82652		<1%	106	$2K
84703		<1%	2,196	$2K
87045		<1%	213	$2K
86361		<1%	50	$2K
86787		<1%	191	$2K
82627		<1%	65	$2K
84702		<1%	242	$2K
80074		<1%	49	$2K
71045	Radiologic examination, chest; single view	<1%	1,929	$2K
84550		<1%	330	$2K
82977		<1%	239	$1K
86765		<1%	93	$1K
86308		<1%	253	$1K
84156		<1%	350	$1K
87177		<1%	106	$1K
90715		<1%	40	$1K
82533		<1%	49	$1K
83880		<1%	40	$1K
90686		<1%	33	$942.91
99001		<1%	25	$878.85
82308		<1%	25	$843.96
77062		<1%	15	$715.34
73140		<1%	96	$690.03
82150		<1%	114	$688.71
87207		<1%	143	$665.17
86644		<1%	40	$640.17
86645		<1%	52	$542.17
86735		<1%	53	$516.34
72110		<1%	12	$501.22
84484		<1%	1,162	$495.41
84442		<1%	38	$414.65
86039		<1%	68	$405.33
86235		<1%	23	$364.40
86753		<1%	23	$345.14
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	15	$270.00
87430		<1%	326	$230.20
86160		<1%	24	$229.97
84145		<1%	17	$224.39
85014		<1%	92	$196.08
87480		<1%	12	$188.34
87510		<1%	12	$188.34
87660		<1%	12	$188.34
85379		<1%	95	$176.81
85018		<1%	65	$149.62
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,579	$138.30
80050	General health panel	<1%	790	$137.46
86225		<1%	25	$126.78
G0008	Administration of influenza virus vaccine	<1%	13	$119.08
82948		<1%	409	$103.09
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	1,630	$95.96
86593		<1%	25	$89.25
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	850	$83.33
73080		<1%	13	$75.00
J1170	Injection, hydromorphone, up to 4 mg	<1%	284	$74.35
83605		<1%	17	$74.18
J2704	Injection, propofol, 10 mg	<1%	477	$66.61
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	302	$66.18
80320		<1%	122	$65.13
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	792	$56.43
86200		<1%	12	$46.10
87807		<1%	15	$43.50
87040		<1%	13	$39.26
96376		<1%	25	$37.18
81000		<1%	126	$12.00
J2270	Injection, morphine sulfate, up to 10 mg	<1%	71	$11.27
J0690	Injection, cefazolin sodium, 500 mg	<1%	44	$10.20
82272		<1%	13	$1.00
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	0%	14	$0.00
J2765	Injection, metoclopramide hcl, up to 10 mg	0%	13	$0.00
99080		0%	1,000	$0.00
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHULTHEIS, CHRISTOPHER (CFO/VP OF FINANCE)

Parent organizationUNIVERSITY HOSPITAL AT STONY BROOK